GlobeNewswire

Open Source Strategy Forum Announces 2018 Event in London and Opens Call for Papers

Dela

PALO ALTO, Calif., March 06, 2018 (GLOBE NEWSWIRE) -- Symphony Software Foundation (the Foundation), the nonprofit organization fostering open source software innovation in financial services, will be hosting its second Open Source Strategy Forum on November 14, 2018. Following a successful 2017 event at BNY Mellon in New York City, the Open Source Strategy Forum moves this year to London, another global epicenter of financial services and the fintech revolution. The Call For Papers and Sponsor  Application links are open today.

Last year's inaugural event attracted over 300 attendees from the world's leading financial services institutions, fintechs, integrators, and vendors. The program featured keynotes from thought leaders across open source and financial services, 28 presentations, and several interactive panel sessions. It featured industry-leading speakers such as Amber Baldet (J.P. Morgan), Jim Jagielski (Capital One, The Apache Software Foundation), John Stecher (Barclays), whurley (William Hurley of Goldman Sachs), Heather Meeker (O'Melveny & Myers), Nithya Ruff (Comcast), Cynthia Rich (GitHub), and Joe McCann (NodeSource).

This year, OSSF maintains its focus on executives, senior technologists, and compliance professionals from financial services firms seeking to drive innovation through open source. It will also expand its focus to engage financial services developers consuming, building, and contributing to open source technology. Abundant networking time will be built into the schedule to foster collaboration and community building.

Attendees will hear from financial technology leaders about how to leverage open source to accelerate their business goals. They'll also learn how to implement best practices for open source collaboration, integrate open source into the enterprise software supply chain, and overcome the technical and compliance hurdles unique to financial services. The event is produced by the Symphony Software Foundation, which has a diverse membership across financial services institutions and platform organizations, as well as proven experience in facilitating open source innovation in financial services.

"Adopting the open source methodology is only a part of the equation. Like in any change management process, business value ultimately drives decisions at all levels. It's only when executives realize the "why"-the true potential of leveraging open source in furthering their business strategy-that fruitful open source engagement will happen," said Gabriele Columbro, Executive Director, Symphony Software Foundation. "This year's Open Source Strategy Forum will bring together Wall Street leaders and the grassroots developer community to make that engagement a reality, marrying the needs of the modern technical workforce with the requirements of decision-makers."

Jim Jagielski, Co-Founder and Vice Chairman, Apache Software Foundation, said, "This event is an important and increasingly vital opportunity for financial services to obtain real-world knowledge related to consuming and contributing back to open source software under unique fintech conditions. Last year's inaugural event was a supreme success and filled a long-standing void in the finserv ecosystem by focusing directly on the issues and solutions applicable to that community. As financial services companies drive towards innovation and a true digital strategy, the Open Source Strategy Forum is the premier, 'go-to' conference and a 'must-attend' event."

The Open Source Strategy Forum hosts talks from bank executives, open source and enterprise thought leaders, and experienced attorneys. Sessions will range from short TED-style talks to longer, in-depth sessions related to both business and technology strategy challenges, as well as developer content on innovative open source fintech technologies.

Sign up for updates on the Open Source Strategy Forum and submit a Call For Papers and Sponsor  ApplicationEmail us at press@symphony.foundation for more details.

About Symphony Software Foundation

The Symphony Software Foundation is an independent non­profit organization building an open source community and development ecosystem to foster innovation in financial services. Its community leverages Symphony, open source platforms, and open standards to drive efficient inter-firm collaboration in this industry. The Foundation offers an Open Developer Platform (ODP) to all its open source contributors, providing open API access to Symphony and a compliant open source development process.

Foundation OSS Projects are Apache 2.0 licensed and available on GitHub

To access the ODP, visit our documentation

To learn more about OSSF, visit opensourcestrategyforum.org

To become a member symphony.foundation/#become-a-member

Photos accompanying this announcement are available at

http://www.globenewswire.com/NewsRoom/AttachmentNg/497bcbe5-4b23-464b-96e7-d5e552f86d9e

http://www.globenewswire.com/NewsRoom/AttachmentNg/60ca70fc-b1b4-4851-9a83-2d50e6ffbf5e

For more information: 
On behalf of Symphony Software Foundation
Tinne Teugels
Email: tinne@symphony.foundation press@symphony.foundationCall: +1 (646) 520 5548




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Symphony Software Foundation via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden. Endast mejladress behövs och den används bara här. Du kan avanmäla dig när som helst.

Senaste pressmeddelandena från GlobeNewswire

Karolinska Development delays publication of its Annual Report for 2018 and changes date for the Annual General Meeting26.4.2019 08:00:00 CESTPressmeddelande

STOCKHOLM, SWEDEN - 26 April 2019. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces today that The Board of Directors has decided to delay the publication of its Annual Report for 2018. Karolinska Development has changed the date for the Annual General Meeting to June 26, 2019. The date for publication of the Annual Report for 2018 has been changed from April 26 to April 30, 2019. Karolinska Development has changed the date for the Annual General Meeting from June 4 to June 26, 2019. Notice to the Annual General Meeting will be published in a separate press release. For more information, please contact: Viktor Drvota, CEO, Karolinska Development AB Phone: +46 73 982 52 02, e-mail: viktor.drvota@karolinskadevelopment.com Fredrik Järrsten, CFO, Karolinska Development AB Phone: +46 70 496 46 28, e-mail: fredrik.jarrsten@karolinskadevelopment.com TO THE EDITORS About Karolinska Development AB Karolinska Development AB (Nasdaq Stockholm: KDEV) is a Nordic life sciences investmen

Karolinska Development senarelägger publicering av årsredovisningen för 2018 och meddelar nytt datum för årsstämma26.4.2019 08:00:00 CESTPressmeddelande

STOCKHOLM, SVERIGE - 26 april 2019. Karolinska Development AB (Nasdaq Stockholm: KDEV) meddelar idag att styrelsen har beslutat att senarelägga publiceringen av årsredovisningen för 2018. Karolinska Development har ändrat datum för årsstämman till den 26 juni 2019. Publiceringen av årsredovisningen för 2018 flyttas från den 26 april till den 30 april 2019. Karolinska Development har ändrat datum för årsstämman från den 4 juni till den 26 juni 2019. Kallelse till årsstämman kommer att publiceras senare i ett separat pressmeddelande. För ytterligare information, vänligen kontakta: Viktor Drvota, vd, Karolinska Development AB Tel: +46 73 982 52 02, e-mail: viktor.drvota@karolinskadevelopment.com Fredrik Järrsten, finanschef, Karolinska Development AB Tel: +46 70 496 46 28, e-mail: fredrik.jarrsten@karolinskadevelopment.com TILL REDAKTÖRERNA Om Karolinska Development AB Karolinska Development AB (Nasdaq Stockholm: KDEV) är ett nordiskt investmentbolag inom life science. Bolaget fokuserar p

Karolinska Developments portföljbolag Aprea Therapeutics har fått särläkemedelsstatus och snabbspårstatus från FDA för APR-24616.4.2019 12:46:00 CESTPressmeddelande

STOCKHOLM, SVERIGE - 16 april 2019. Karolinska Development AB meddelar idag att portföljbolaget Aprea Therapeutics har av FDA fått särläkemedelsstatus för APR-246 för behandling av patienter med TP53-muterad myelodysplastiskt syndrom (MDS). Dessutom ger FDA bolaget snabbspårstatus (Fast Track Designation), för APR-246 för behandling av MDS. Amerikanska läkemedelsverket, FDA, ger särläkemedelsstatus till läkemedelskandidater för att snabba på utvärderingen och utvecklingen av säkra och effektiva behandlingar av ovanliga sjukdomar. Särläkemedelsstatus ger företag både regulatoriska och kommersiella incitament genom att läkemedlet får marknadsexklusivitet på den amerikanska marknaden i sju år efter marknadsgodkännande samtidigt som företaget får stöd från FDA när det gäller designen av kliniska prövningar, skatteförmåner för kostnader kopplade till kliniska prövningar och avgiftsbefrielse från FDA. FDA:s snabbspår underlättar utvecklingen av läkemedel som är avsedda för att behandla allva

Karolinska Development's portfolio company Aprea Therapeutics has received FDA Orphan Drug Designation and Fast Track Designation for APR-24616.4.2019 12:46:00 CESTPressmeddelande

STOCKHOLM, April 16, 2019. Karolinska Development's portfolio company Aprea Therapeutics has from FDA received an Orphan Drug Designation for APR-246 for the treatment of patients with Myelodysplastic Syndromes (MDS) having a TP53 mutation. In addition, FDA has also granted Fast Track Designation to APR-246 for treatment of MDS. Orphan Drug Designation is granted by the FDA Office of Orphan Products Development to advance the evaluation and development of safe and effective therapies for the treatment of rare diseases. The designation can provide development and commercial incentives for designated compounds and medicines, including eligibility for a seven-year period of market exclusivity in the U.S. after product approval, FDA assistance in clinical trial design, tax credits related to clinical trial expenses, and an exemption from FDA user fees. The FDA's Fast Track program facilitates the development of drugs intended to treat serious conditions and that have the potential to addre

Bergman & Beving AB: Bergman & Beving förvärvar KGC10.4.2019 14:00:00 CESTPressmeddelande

Pressmeddelande Bergman & Beving förvärvar KGC Bergman & Beving har idag tecknat avtal om förvärv av samtliga aktier i KGC Verktyg & Maskiner AB. KGC, med säte i Älvsjö, har i mer än 60 år utvecklat och levererat kvalitetsverktyg och tillbehör för murning och plattsättning i det egna varumärket KGC. Bolaget omsätter cirka 80 MSEK per år, och har 24 anställda. "KGC är ett ledande varumärke med högt anseende hos murare och plattsättare och har en mycket stark ställning på den svenska marknaden", säger Pontus Boman, VD och koncernchef. Tillträde beräknas ske den 1 maj 2019 och förvärvet bedöms ha en marginellt positiv påverkan på Bergman & Bevings resultat per aktie under innevarande räkenskapsår. Stockholm den 10 april 2019 Bergman & Beving AB (publ) För ytterligare information kontakta: Pontus Boman, VD & Koncernchef, telefon 010-454 77 00 Peter Schön, CFO, telefon 070-339 89 99 Denna information lämnades, genom ovanstående kontaktpersoners försorg, för offentliggörande den 10 april 201

Bergman & Beving AB: Bergman & Beving acquires KGC10.4.2019 14:00:00 CESTPressmeddelande

Press release Bergman & Beving acquires KGC Bergman & Beving has today signed an agreement to acquire all shares in KGC Verktyg & Maskiner AB. KGC, based in Älvsjö, has for more than 60 years developed and delivered quality tools and accessories for bricklayers and tilers in its own brand KGC. The business has a turnover of approximately SEK 80 million per year, and has 24 employees. "KGC is a leading brand with high reputation among bricklayers and tilers and has a very strong position in the Swedish market," says Pontus Boman, President and CEO. The closing is taking effect on 1 May 2019 and the acquisition is expected to have a marginal positive impact on Bergman & Beving's earnings per share during the current fiscal year. Stockholm, 10 April 2019 Bergman & Beving AB (publ) For further information, please contact: Pontus Boman, President & CEO, Tel: +46 10 454 77 00 Peter Schön, CFO, Tel: +46 70 339 89 99 The information was submitted for publication, through the agency of the cont

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum